Isonicotinylation is a histone mark induced by the anti-tuberculosis first-line drug isoniazid | Nature Communications
Isonicotinylation is a histone mark induced by the anti-tuberculosis first-line drug isoniazid | Nature Communications
Modeling early bactericidal activity in murine tuberculosis provides insights into the activity of isoniazid and pyrazinamide | PNAS
Toxicoproteomic Profiling of hPXR Transgenic Mice Treated with Rifampicin and Isoniazid
Improving treatment outcome assessment in a mouse tuberculosis model | Scientific Reports
Effect of niacin supplementation on nausea-like behaviour in an isoniazid-induced mouse model of pellagra | British Journal of Nutrition | Cambridge Core
Direct Oxidation and Covalent Binding of Isoniazid to Rodent Liver and Human Hepatic Microsomes: Humans Are More Like Mice than Rats | Chemical Research in Toxicology
Xanthohumol from Humulus lupulus L. potentiates the killing of Mycobacterium tuberculosis and mitigates liver toxicity by the combination of isoniazid ... - RSC Advances (RSC Publishing) DOI:10.1039/C9RA10347C
Xanthohumol from Humulus lupulus L. potentiates the killing of Mycobacterium tuberculosis and mitigates liver toxicity by the combination of isoniazid ... - RSC Advances (RSC Publishing) DOI:10.1039/C9RA10347C
JCI Insight - Interleukin-17 limits hypoxia-inducible factor 1α and development of hypoxic granulomas during tuberculosis
NOS2-deficient mice with hypoxic necrotizing lung lesions predict outcomes of tuberculosis chemotherapy in humans | Scientific Reports
Epidemiology in History Ficacy, Effectiveness, Toxicity, Durability, and Duration | PDF | Tuberculosis | Hiv/Aids
Assessing whether isoniazid is essential during the first 14 days of tuberculosis therapy: a phase 2a, open-label, randomised controlled trial - ScienceDirect
Modeling early bactericidal activity in murine tuberculosis provides insights into the activity of isoniazid and pyrazinamide | PNAS
A long-acting formulation of rifabutin is effective for prevention and treatment of Mycobacterium tuberculosis | Nature Communications
Efficacy and Improved Resistance Potential of a Cofactor-Independent InhA Inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ Mouse Model | Antimicrobial Agents and Chemotherapy
A Physiologically Based Pharmacokinetic Model of Isoniazid and Its Application in Individualizing Tuberculosis Chemotherapy | Antimicrobial Agents and Chemotherapy
A Physiologically Based Pharmacokinetic Model of Isoniazid and Its Application in Individualizing Tuberculosis Chemotherapy | Antimicrobial Agents and Chemotherapy
Direct Oxidation and Covalent Binding of Isoniazid to Rodent Liver and Human Hepatic Microsomes: Humans Are More Like Mice than Rats | Chemical Research in Toxicology
Effect of niacin supplementation on nausea-like behaviour in an isoniazid-induced mouse model of pellagra | British Journal of Nutrition | Cambridge Core
Isonicotinylation is a histone mark induced by the anti-tuberculosis first-line drug isoniazid | Nature Communications
Assessing whether isoniazid is essential during the first 14 days of tuberculosis therapy: a phase 2a, open-label, randomised controlled trial - ScienceDirect
Isonicotinylation is a histone mark induced by the anti-tuberculosis first-line drug isoniazid | Nature Communications
Efficacy and Improved Resistance Potential of a Cofactor-Independent InhA Inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ Mouse Model | Antimicrobial Agents and Chemotherapy
Studies of the Specific Activity of Aerosolized Isoniazid against Tuberculosis in a Mouse Model
Isoniazid Oral Solution - CMP Pharma
